Submit Deal

TOLERANZIA AB

HQ - Gothenburg

Summary

Toleranzia AB is a biotechnology company that focuses on developing immunotherapies for the treatment of autoimmune diseases.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 10 M

Avg. Deal Size£ 10 M

Market Context

Senior Management

Sort

Target: TOLERANZIA AB

Bidder: FLERIE INVEST

3 Service Providers

2 Dealmakers

£ 10 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy